Trial no.:
|
PACTR201401000720267 |
Date of Approval:
|
04/12/2013 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Project goal is eliminate HIV within all systems of the body and to prevent its transmission. |
Official scientific title |
Randomized, Double Blind, Placebo-Controlled Trial of an Advanced Fused Silver Water formula in HIV-1 infected, Tuberculosis and Malaria in the Kingdom of Lesotho and Republic of South Africa. |
Brief summary describing the background
and objectives of the trial
|
Acquired Human Immunodeficiency Syndrome (AIDS) is a disease which targets and depletes the body¿s T helper cells. It is caused by the Human Immunodeficiency Virus type 1 (HIV_1). Viral load, as measured in Peripheral Blood Mononuclear Cells (PBMCs) cultures, have been shown to correlate with early disease progression and loss of CD4 cells. Similarly suppression of viral replication by an antiretroviral agent in Vitro is a clear indication that such an agent, could be a potential candidate for treatment of HIV_1 infection. A broad spectrum anti-viral agent that really works is needed to combat immune system diseases. This includes some of the most formidable viral organisms like HIV (including co-infections), Tuberculosis, and Malaria.
In these experiment 200 patients in Lesotho and South Africa, PHA-stimulated PBLs infected with HIV_1 JRCSF will be treated with Silver water formula agent.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
UPCOSH Lesotho Trial |
Disease(s) or condition(s) being studied |
Infections and Infestations,upper respiratory tract infections |
Sub-Disease(s) or condition(s) being studied |
HIV/AIDS,Malaria,Tuberculosis |
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
18/03/2015 |
Actual trial start date |
17/04/2014 |
Anticipated date of last follow up |
17/03/2015 |
Actual Last follow-up date |
17/03/2016 |
Anticipated target sample size (number of participants) |
200 |
Actual target sample size (number of participants) |
100 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|